Insulin Resistance

The supplied reviews support obesity-linked insulin resistance as a major cause pattern, including obesity-induced inflammation and adipocyte hypertrophy. Hypoadiponectinemia, influenced by genetic factors such as adiponectin gene SNPs and environmental factors causing obesity, is described as playing an important causal role. High-fat diet is also implicated in the grounding as a studied mechanism associated with insulin resistance.

Insulin resistance involves reduced tissue responsiveness to insulin, with defects in glucose uptake and oxidation, reduced glycogen synthesis, and impaired suppression of lipid oxidation. The grounding highlights chronic low-level inflammation, altered adipokine signaling, and downregulation of adiponectin and its receptors as mechanisms that interfere with insulin sensitivity. It is also associated with oxidative stress, disturbed lipid and energy metabolism, and changes in signal transduction pathways.

Obesity is the clearest risk factor supported by the grounding, especially obesity with adipocyte hypertrophy and visceral adipose inflammation. High-fat diet is also associated with insulin resistance in the supplied literature. Genetic variation affecting adiponectin is another supported risk factor.

The grounding supports treatment at the drug-class level with insulin-sensitizing therapy, particularly thiazolidinediones, which are described as increasing adiponectin as part of their antidiabetic action. Metformin is also among the co-studied drugs, indicating its relevance in management. The literature additionally points to adiponectin and adiponectin receptors as potential therapeutic targets, but does not provide a broader treatment standard beyond insulin-sensitizing approaches.